UNSPSC 51131819: Coagulation factor ix

This classification denotes an antifibrinolytic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 382L14738L. European Medicines Agency schedules Coagulation factor ix in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12030MIG. Coagulation factor ix bears US NLM identifiers UMLS ID C0015491 and NCI Concept Code C28482.

UNSPSC 51131819 Coagulation factor ix is a Commodity code that describes pharmaceutical blood-clotting products used in medical treatment, but the recent state and local contract opportunities associated with this code show little alignment with its nominal scope. The single recent solicitation posted under this code is Sourcewell RFP #061626, issued on behalf of the State of Minnesota and its participating entities, which solicits law enforcement equipment — body armor, weapons, tactical gear, and related protective equipment — rather than coagulation factors or any pharmaceutical products. This mismatch suggests either a tagging error in the state or local procurement system or a data classification inconsistency in how the opportunity was indexed.

Activity under this code across state and local buyers appears minimal or misaligned with the code's pharmaceutical intent. The lone representative opportunity, Sourcewell RFP #061626, closed June 16, 2026, and operated as a cooperative purchasing vehicle administered by Sourcewell (a Minnesota local government unit) on behalf of participating entities including Franklin, Grant, Grays Harbor, Chelan, and Yakima Counties in Washington, along with numerous other jurisdictions nationwide and in Canada. No additional recent opportunities under this code are present in the source material. Business development professionals evaluating this code should clarify whether procurement activity genuinely reflects demand for coagulation factor ix products — which would typically be sourced through state Medicaid programs, corrections departments, or public health agencies — or whether the code assignment reflects a classification anomaly in the underlying procurement data.